Ignite Creation Date:
2025-12-25 @ 3:22 AM
Ignite Modification Date:
2026-03-03 @ 12:08 PM
Study NCT ID:
NCT01698905
Status:
COMPLETED
Last Update Posted:
2025-09-02
First Post:
2012-10-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-12-20
Start Date Type:
ACTUAL
Primary Completion Date:
2015-11-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-01-29
Completion Date Type:
ACTUAL
First Submit Date:
2012-10-01
First Submit QC Date:
None
Study First Post Date:
2012-10-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-12-17
Results First Submit QC Date:
None
Results First Post Date:
2021-01-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-12
Last Update Post Date:
2025-09-02
Last Update Post Date Type:
ESTIMATED